According to a research report titled ‘Global Immunohistochemistry Market 2019-2027’ available with Market Study Report, global immunohistochemistry market is projected to grow at compound annual rate of 7.11% during the forecast period 2020-2027.
 

As per report findings, increasing prevalence of cancer, rising geriatric population, and advancements in healthcare infrastructure are fueling worldwide immunohistochemistry market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2487045/
 

Further, the market giants can grasp key opportunities such as the developments in the field of technological healthcare and diagnosis of diseases by using biomarkers to establish their base.
 

However, factors such as system restrictions, reimbursement issues, and uninsured population are anticipated to impede business development in the forthcoming years. Moreover, rigid rules & regulations coupled with additional maintenance costs associated with immunochemistry pose a challenge to businesses operating in this domain.
 

Based on product type, global immunohistochemistry market is arrayed into antibodies (primary and secondary), equipment (slide scanners, slide staining systems, tissue processing systems, tissue microarrays, and others), reagents (stabilizers, histological stains, organic solvents, blocking sera and reagents, fixation, chromogenic substrates, proteolytic enzymes, and diluents) and kits.
 

Moving on to applications, the industry is classified into diagnostics (infectious diseases, cancer, cardiovascular disease, diabetes mellitus, autoimmune diseases, nephrological diseases) and drug testing.
 

Elaborating on end-user spectrum, the industry is comprised of hospitals and diagnostic centers, and research institutes.
 

On the regional front, North America currently holds a significant portion of global immunohistochemistry market share. Rising demand for quality healthcare and high healthcare expenditure are driving regional market growth. Meanwhile, Asia-Pacific region is expected to generate significant returns during the forecast period.
 

Top contenders in global immunohistochemistry market space are Abbott Laboratories, Agilent Technologies Inc., Abcam PLC, Bio-Genex Laboratories, Bio SB Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Histologix Ltd., PerkinElmer Inc., F. Hoffmann-La Roche A.G, Thermo Fisher Scientific Inc., Cell Signaling Technology Inc., Merck Millipore, and Siemens Healthineers A.G.